Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients: A Nationwide Data Survey and Propensity Analysis

Long-term benefit of using a renin–angiotensin–aldosterone system blocker such as an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) for patients already receiving dialysis remains undetermined. The aim of this study is to assess the efficacy and safety of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Medicine (Baltimore)
Päätekijät: Wu, Cho-Kai, Yang, Yao-Hsu, Juang, Jyh-Ming Jimmy, Wang, Yi-Chih, Tsai, Chia-Ti, Lai, Ling-Ping, Hwang, Juey-Jen, Chiang, Fu-Tien, Chen, Pau-Chung, Lin, Jiunn-Lee, Lin, Lian-Yu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wolters Kluwer Health 2015
Aiheet:
3400
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4602640/
https://ncbi.nlm.nih.gov/pubmed/25621694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000000424
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia